Can you provide the precise date for apotex's ruxolitinib fda submission?

What is the exact FDA submission date for Apotex’s ruxolitinib?

I can’t provide a precise submission date from the information provided to me. The FDA submission date you’re asking for is not included in the provided materials, and I don’t have access to FDA records or Apotex’s application history in this chat.

Where to find the precise date (and what to look for)

To get the exact date, check FDA’s public drug-application records for Apotex’s ruxolitinib submission (typically shown as a “submission date” on the relevant listing, docket, or review record). Search specifically for:
- Apotex’s ruxolitinib entry in FDA databases (the record page usually lists the submission date)
- Any FDA docket materials tied to the application
- The Orange Book–linked or NDA/ANDA-related listing that corresponds to Apotex’s product

If you share the specific FDA application type/identifier you’re using (e.g., NDA/ANDA number, product name, or an FDA link), I can tell you exactly where the submission date appears on that record and how to interpret it.

If you meant the initial generic vs. an amendment date

FDA “submission date” can be confused with later events like:
- amendments or supplements (often showing later dates)
- review start dates
- approval dates

If you confirm whether you want the initial filing date or the first supplement date, I can help you pin down the correct one once the underlying FDA record is identified.

Sources

No sources were provided.